You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade subcutaneous

Showing 1 - 25 of 3,836
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Torino (velcade subcutaneous melphalan prednisone, velcade cyclophosphamide prednisone, velcade

Active, not recruiting
  • Multiple Myeloma
  • velcade subcutaneous melphalan prednisone
  • +2 more
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino - SC Ematolo
Mar 24, 2022

Subcutaneous Velcade at Home of Patients With Myeloma.

Recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
Dec 17, 2021

Multiple Myeloma Trial in United States (Bortezomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Denver, Colorado
  • +7 more
Feb 11, 2022

Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +29 more
Apr 4, 2023

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Multiple Myeloma Trial in Ireland (lenalidomide, Subcutaneous bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Waterford, Co Waterford, Ireland
  • +7 more
Jul 16, 2020

Multiple Myeloma Trial in China (Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Beijing, China
  • +9 more
Nov 7, 2019

GVHD Trial in Sacramento (Bortezomib)

Completed
  • Graft Versus Host Disease
  • Sacramento, California
    University of California Comprehensive Cancer Center
May 26, 2020

Waldenstrom's Macroglobulinaemia Trial in United Kingdom (Bortezomib, Cyclophosphamide, Rituximab)

Completed
  • Waldenstrom's Macroglobulinaemia
  • Basingstoke, United Kingdom
  • +29 more
Jun 17, 2021

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Jan 17, 2023

Lymphoma, Mantle- Cell Trial in United States (Everolimus)

Completed
Has Results
  • Lymphoma, Mantle- Cell
  • Multiple Locations, Arizona
  • +30 more
Apr 30, 2021

AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

Recruiting
  • AL Amyloidosis
  • Orange, California
  • +5 more
May 3, 2022

Plasma Cell Myeloma Trial in Worldwide (lenalidomide, bortezomib, cyclophosphamide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Nantes Cedex 01, France
  • +11 more
May 3, 2022

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Multiple Myeloma Trial in Germany (Bendamustine, Bortezomib, Prednisone)

Completed
  • Multiple Myeloma
  • Bendamustine, Bortezomib, Prednisone
  • Mannheim, Ba-Wü, Germany
  • +14 more
Oct 14, 2020

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Multiple Myeloma Trial in Germany (elotuzumab, Lenalidomide, Bortezomib)

Completed
  • Multiple Myeloma
  • Aschaffenburg, Germany
  • +67 more
Sep 9, 2021

IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +2 more
  • (no location specified)
Oct 27, 2023

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Multiple Myeloma Trial in Chicago, Milwaukee (Bortezomib, Isatuximab, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +1 more
Mar 14, 2022